New Weight Loss Drugs Show Promise for People With HIV

Weight loss drugs that have made headlines worldwide might offer new hope for people living with HIV who struggle with obesity and related health problems.

In South Africa, the story of HIV and weight has completely flipped. While the disease was once associated with severe weight loss before treatments became available, people living with HIV today often face the opposite problem. Obesity now disproportionately affects Black women with HIV, creating what researchers call one of the biggest public health challenges in high HIV areas.

The shift happened as HIV treatments improved and became more widely available. As people started living longer, healthier lives with HIV, weight gain became increasingly common. But this success brought new complications.

People with HIV face a triple threat when it comes to health risks. They're already predisposed to develop heart disease, diabetes, and other conditions at younger ages than people without HIV. Add obesity to the mix, and those risks climb even higher. Even when the virus is well controlled with medication, low level chronic inflammation can cause ongoing problems.

That's where drugs like Ozempic and Wegovy come in. These GLP-1 medications have shown remarkable results for weight loss in the general population. Now researchers are discovering they work similarly well for people with HIV.

Dr. Nomathemba Chandiwana from the Desmond Tutu Health Foundation has been tracking this research closely. So far, only three small clinical trials have tested these drugs in people with HIV, involving fewer than 200 participants total. One groundbreaking trial took place in rural KwaZulu-Natal, South Africa, led by Dr. Jenn Manne-Goehler from Harvard Medical School.

The early results are encouraging. According to the European AIDS Clinical Society, people with HIV can expect the same weight loss from these medications as people without HIV. The drugs also appear to be safe for HIV patients to use alongside their regular medications.

Researchers have also studied health records from people with HIV who are already using these drugs in developed countries. This real world evidence backs up what the small trials showed: the medications deliver similar weight loss results regardless of HIV status.

The Bright Side

While more research is definitely needed, these early findings open doors that seemed closed just a few years ago. For decades, people with HIV had limited options for managing obesity beyond diet and exercise, which studies show have limited long term impact on their own.

Now there's scientific evidence that these breakthrough medications can work for them too. As rates of diabetes, heart disease, and other weight related conditions continue rising among people aging with HIV, having effective tools to manage weight becomes increasingly critical.

The challenge now is making these medications accessible and affordable, especially in South Africa where both HIV and obesity rates are high. But knowing these drugs work safely and effectively for people with HIV is an important first step toward addressing what researchers consider a major public health issue.

This research represents real progress in helping people with HIV live not just longer lives, but healthier ones too.